- Udyam number
- UDYAM-MH-26-0406895

About Fortessa Pharma Private Limited
Data last updated:
Fortessa Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2021PTC197796. Its GSTIN is 27AAECF4052C1Z1 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Kamlesh Kantilal Pathak and Shital Ashok Pawar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.01 Cr, a growth of 111% compared to the previous year. For the same year it recorded a net profit of ₹6.84 Lakh (net margin 0.7%) and EBITDA of ₹12.11 Lakh (EBITDA margin 1.2%).
As per MCA filings, the company has open charges of ₹2.5 Cr on record.
Fortessa Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-26-0406895). For more details, the company can be reached via its website fortessapharma.in.
Company details
Recognitions & Rankings of Fortessa Pharma
Contact details
Fortessa Pharma Private Limited's registered office is in Pune, Maharashtra. Its website is fortessapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. A – 601 6th Floor Savoire Faire Apartment, Sr No. 23 Behind Moze Collage, Pune, Maharashtra, India – 411045
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Fortessa Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fortessa Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fortessa Pharma Private Limited, buy the company report.
Financials of Fortessa Pharma Private Limited
FY 2025 filings availableFortessa Pharma Private Limited reported revenue of ₹10.01 Cr (up 111% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 111% in the latest year. EBITDA rose 832% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹12.11 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6.84 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.2% | |||
| Net Profit Margin | 0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Fortessa Pharma Private Limited, buy the company report.
Board of directors of Fortessa Pharma Private Limited
Fortessa Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamlesh Kantilal Pathak | Director | 18 Jan 2021 | 5 Years 9 Months | Current |
| Shital Ashok Pawar | Director | 02 Dec 2023 | 2 Years 11 Months | Current |
Peer comparison
Fortessa Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maikal Kanya International Private Limited | ₹10.02 Cr (FY 2025) | 502.0% | Indore, Madhya Pradesh, India | |||
| Kash Logistics Private Limited | ₹10.02 Cr (FY 2024) | -31.0% | New Delhi, Delhi, India | |||
| Fortessa Pharma Private Limitedthis company | ₹10.01 Cr (FY 2024) | ₹6.84 Lakh | 0.7% | 111.0% | Pune, Maharashtra, India | |
| Uniserve Distributors Private Limited | ₹10.01 Cr (FY 2023) | 11.0% | Kollam, Kerala, India | |||
| Try Bird Healthcare Private Limited | ₹10 Cr (FY 2024) | 6.0% | Chandigarh, India | |||
| Civanta Distributors Private Limited | ₹10 Cr (FY 2024) | 3355.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Fortessa Pharma Private Limited, buy the company report.
Auditor
Fortessa Pharma Private Limited is audited by Amit G Malu & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Amit G Malu & Associates | FY 2023 | 138064W |
Shareholding
The shareholding of Fortessa Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Fortessa Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jan 2026 | 101221274 | Others | ₹2.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Fortessa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fortessa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fortessa Pharma Private Limited has 1 active EPFO establishment as of Nov 11, 2026.
GST
Fortessa Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECF4052C1Z1 | Maharashtra | Active | 15 Feb 2021 |
To see the full GST registrations and return filing status of Fortessa Pharma Private Limited, buy the company report.
Recent activity
Fortessa Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Nikita Dipak Bagul ceased to be Director on 02 Dec 2023.
Frequently asked questions
Fortessa Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 January 2021 (5+ years old) and is registered under CIN U51909PN2021PTC197796.
Fortessa Pharma has 2 current directors:
- Kamlesh Kantilal Pathak - Director
- Shital Ashok Pawar - Director
The latest financial statements of Fortessa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Fortessa Pharma is 27AAECF4052C1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Fortessa Pharma is U51909PN2021PTC197796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fortessa Pharma was incorporated on 18 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Fortessa Pharma by revenue are Maikal Kanya International Private Limited, Kash Logistics Private Limited, Uniserve Distributors Private Limited, Try Bird Healthcare Private Limited, Civanta Distributors Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Nikita Dipak Bagul ceased to be Director on 02 Dec 2023. Shital Ashok Pawar was appointed as Director on 02 Dec 2023. Kamlesh Kantilal Pathak was appointed as Director on 18 Jan 2021. Fortessa Pharma has 4 board changes on record in total.
Yes, Fortessa Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-26-0406895).
Fortessa Pharma can be reached through the website fortessapharma.in. Its registered office is in Pune, Maharashtra, India.
The registered office of Fortessa Pharma is at Flat No. A – 601 6th Floor Savoire Faire Apartment, Sr No. 23 Behind Moze Collage, Pune, Maharashtra, India – 411045.

